Clinical Trial Update: A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update of Aneustat (OMN54) in patients with advanced cancer and lymphomas has completed. The document lists the study status as COMPLETED…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Lymphoma

Drugs mentioned

• Aneustat (OMN54)

Snippet

Sponsor: Omnitura Therapeutics, Inc. | Conditions: Neoplasms | Phase 1 | Status: COMPLETED